Posted by Doug Wharley on Nov 19th, 2024
Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Free Report) was the recipient of a significant decrease in short interest during the month of October. As of October 31st, there was short interest totalling 37,040,000 shares,...
More of this article »